Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesFatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study
BMC Cancer, 07/02/09
Kim J et al. - In a study to examine the association between fish and fish omega-3 fatty acids intake with the risk of breast cancer in a case-control study of Korean women, these results suggest that high consumption of fatty fish is associated with a reduced risk for breast cancer, and that intake of omega-3 fatty acids from fish is inversely associated with postmenopausal breast cancer risk.
Methods- 358 incident breast cancer pts and 360 controls were recruited with no history of malignant neoplasm.
- Study participants were given a 103-item food intake frequency questionnaire to determine their dietary consumption of fish (fatty and lean fish) and omega-3 fatty acids derived from fish (eicosapentaenoic acid [EPA], and docosahexaenoic acid [DHA]).
- Using a multivariate logistic regression model, high intake of fatty fish was associated with reduced risk for breast cancer in both pre- and postmenopausal women.
- Reductions in breast cancer risk were observed among postmenopausal subjects who consumed more than 0.101 g of EPA and 0.213 g of DHA from fish per day vs the reference group who consumed <0.014 g of EPA and <0.037 g of DHA per day.
- Among premenopausal women, there was a significant reduction in breast cancer risk for the highest intake quartiles of omega-3 fatty acids vs the reference group who consumed the lowest quartile of intake.
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group
Journal of Clinical Oncology, 10/19/09
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
Annals of Oncology, 10/13/09
Pomegranate fruit extract impairs invasion and motility in human breast cancer
Integrative Cancer Therapies , 10/12/09
Sponsor
Article Search
Sponsor
Sponsor